Skip to main content

Table 1 Demographic and biochemical characteristics of normal subjects, prodromal AD, and AD dementia

From: Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease

Demographic data/molecules in CSF or plasma

Total numbers of subjects

Normal

Prodromal AD

AD dementia

p value

Number of subjects

101

50

23

28

 

Age

101

72.0 (6.1)

71.1 (8.6)

69.4 (6.0)

0.262

Years of education

101

9.5 (5.0)

8.0 (4.7)

6.70 (3.8) a

0.033

Gender, female, n (%)

101

26.0 (52.0)

12 (52.2)

17.0 (60.7)

0.736

K-MMSE score

101

26.8 (2.3)

25.3 (3.9)

17.9 (5.4) a, b

< 0.001

CDR

101

0.3 (0.2)

0.5 (0.0) a

0.9 (0.4) a, b

< 0.001

CDR sum of boxes

101

0.5 (0.6)

1.3 (0.6)

5.1 (2.6) a, b

< 0.001

GDS

101

1.6 (0.5)

3.0 (0.2) a

4.1 (0.9) a, b

< 0.001

B-ADL

101

20.0 (0.0)

20.0 (0.2)

19.0 (1.8) a, b

< 0.001

I-ADL

101

0.04 (0.08)

0.22 (0.14) a

0.63 (0.20) a, b

< 0.001

CSF biomarkers

 Aβ1–42, pg/ml

101

1,059 (177)

550 (223) a

484 (192) a

< 0.001

 t-Tau, pg/ml

101

230 (77)

389 (236) a

536 (209) a, b

< 0.001

 p-Tau181, pg/ml

101

44 (14)

66 (33) a

78 (28) a

< 0.001

 BK, pg/ml

72

83 (49)

55 (45)

39 (33) a

0.002

Plasma factors

 FXIIa, U/ml

101

23.90 (3.70)

28.0 (3.4) a

30.6 (3.7) a

< 0.001

 FXIa, U/ml

101

1.11 (0.21)

1.18 (0.21)

1.30 (0.30) a

0.005

 FXa, U/ml

101

0.77 (0.11)

0.81 (0.12)

0.97 (0.29) a, b

< 0.001

 Kallikrein, U/ml

101

1.20 (0.25)

1.35 (0.34)

1.54 (0.39) a

< 0.001

 BK, pg/ml

90

13,365 (9,305)

13,497 (7,945)

17,679 (21,186)

0.406

  1. Data are presented as mean (± standard deviation) or number (%). Abbreviations: K-MMSE Korean Mini-Mental State Examination, CDR Clinical Dementia Rating, GDS Global Deterioration Scale, B-ADL Barthel Activities of Daily Living, I-ADL Instrumental Activities of Daily Living, CSF cerebrospinal fluid, amyloid beta-protein, t-Tau total Tau protein, p-Tau phosphorylated Tau protein, AD Alzheimer’s disease, BK bradykinin. astatistically significant difference between the indicated group and the normal group; bstatically significant difference between prodromal AD and AD dementia groups